Table 3.
Self-report | Outcome | Better score | Chemotherapy |
Control |
Baseline: chemotherapy (A1) -control (A1) |
Pre- to postchemotherapy: chemotherapy (A2-A1) - control (A2-A1) |
Prechemotherapy to 6 months follow-up: chemotherapy (A3-A1) - control (A3-A1) |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A1 | A2 | A3 | A1 | A2 | A3 | Adjusted β (SE) | P a | Adjusted β (SE) | P a | Adjusted β (SE) | P a | |||
Adjusted mean (SE) | Adjusted mean (SE) | Adjusted mean (SE) | Adjusted mean (SE) | Adjusted mean (SE) | Adjusted mean (SE) | (95% CI) | (95% CI) | (95% CI) | ||||||
Women | ||||||||||||||
FACT-Cog PCI | Perceived cognitive impairment | Higher | 90.72 (3.08) |
|
|
|
|
|
|
.11 |
|
<.001 |
|
<.001 |
FACT-Cog total score | Perceived cognitive difficulties | Higher |
|
|
|
|
|
|
|
.005 |
|
<.001 |
|
<.001 |
Single item: memory | Perceived memory difficulty | Higher |
|
|
|
|
|
|
|
.10 |
|
<.001 |
|
.002 |
Single item: attention | Perceived attention difficulty | Higher |
|
|
|
|
|
|
|
.03 |
|
<.001 |
|
.045 |
Men | ||||||||||||||
FACT-Cog PCI | Perceived cognitive impairment | Higher |
|
83.23 (2.98) |
|
|
|
|
|
.14 |
|
<.001 |
|
.004 |
FACT-Cog total score | Perceived cognitive difficulties | Higher |
|
|
|
|
|
|
|
.02 |
|
<.001 |
|
.04 |
Single item: memory | Perceived memory difficulty | Higher |
|
|
|
|
|
|
|
.13 |
|
.02 |
|
.04 |
Single item: attention | Perceived attention difficulty | Higher |
|
|
|
|
|
|
|
.21 |
|
.05 |
|
.48 |
Adjusted means, standard errors, 95% confidence intervals (CI), and β estimates are from the longitudinal linear mixed models after adjustment for age, education, race, reading score, baseline anxiety, and baseline depression. Estimates are based on group-by-time-by-sex interaction. All P values are based on 2-sided tests. FACT-Cog = Functional Assessment of Cancer Therapy—Cognitive Function; PCI = perceived cognitive impairment.